The Role of HER2 in Early Breast Cancer Metastasis and the Origins of Resistance to HER2-targeted Therapies

Experimental and Molecular Pathology - United States
doi 10.1016/j.yexmp.2009.05.001
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2016English

Prospective Evaluation of the Cardiac Safety of HER2-targeted Therapies in Patients With HER2-positive Breast Cancer and Compromised Heart Function: The SAFE-HEaRt Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2019English

Targeted Therapy for HER2 Positive Breast Cancer

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2013English

EGFR and HER2 Signaling in Breast Cancer Brain Metastasis

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2016English

Current Landscape of Targeted Therapies for Hormone-Receptor Positive, HER2 Negative Metastatic Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

A Changing Natural History of HER2-positive Breast Cancer Metastatic to the Brain in the Era of New, Targeted Therapies

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Corrigendum: Mechanism of Early Dissemination and Metastasis in Her2+ Mammary Cancer

Nature
Multidisciplinary
2017English

HER2-Orientated Therapy in Early and Metastatic Breast Cancer

Breast Care
SurgeryOncology
2016English

Her2 Cross Talk and Therapeutic Resistance in Breast Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy